Friday, February 15, 2013 5:53:12 PM
How much will this stock tank tomorrow?
A. 0-3%
B. 3-6%
C. 6-9%
D -9%+
E. A miracle happens and we actually go up.
we are up
ELITE = Miracle Stock
- they need 275k more revenue to be profitable,and with 3 products about to launch we are there in the next Q10
- they are profitable on there inventory alone LOL LOL
- the most important reason why someone should invest in elite is because with there ART TECH.,they could in time save millions of lives worldwide and reduce the comming of new addicts. and thus helps us to create a better world.- Elite operates a FDA GMP(Good Manufacturing Practices) and DEA registered facility for research, development, and manufacturing located in Northvale, NJ.
- 5 products beeing manufactured and sold as we speak
- revenue growing 20% each quarter,at this rate we are profitable next quarter.
- 3 products deu to launch in weeks pushing us even closer to CFP
- ELI216-abuse resistant patent is approved and additional pattents that goes allong with the product are on track to be approved very soon.
- elite in the only company in the world able to produce such small microtablets.
- news from the monetizing of there 10% stake in novel could come any day,the extra 25- to 40 million that goes with the sale could send us to a dollar
- when novel sold money can be used to buy more NDA and ANDA
- even with 8 products approved by the FDA this year,the pipeline is still verry impressive,the ART-products allone is good for a nice chunck of the 20 billion dollar pain killer market,they need 4mil now to be CFP LOL LOL LOL
- elite is working on a better embedda,the sky is the limit once its launched
- BE-studies for ELI-216 should be finished in the next few months,elite stated in cc that potential partners have made contact with them
- elite partnered up with some of the largest company's in the pharm. industry
- new facility able to produce larger batches and should save the company 100's of thousand dollars on the 5 products they produce right now
- the only negative i see is that they are not debt free,but debt is only 3.5mil. or abt 5 to 10% of what they gonna get for there stake in NOVEL
- smart investors could buy a million shares as long as its under a dime,wait 3 to 5 year and retire
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/01/2026 11:00:24 AM
- Elite Pharmaceuticals Announces Filing of Abbreviated New Drug Application with the U.S. Food and Drug Administration for Generic Anticoagulant Product • Newsfile • 06/01/2026 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 12:05:23 PM
- Elite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets • Newsfile • 04/02/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 10:10:32 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call Information • Newsfile • 02/17/2026 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:06:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/11/2026 09:35:26 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026 • Newsfile • 02/11/2026 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2026 09:35:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 10:10:23 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information • Newsfile • 11/14/2025 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:11:38 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/12/2025 10:19:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 12:15:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 12:15:46 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025 • Newsfile • 11/10/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2025 09:17:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/22/2025 01:39:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2025 08:37:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2025 08:35:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/25/2025 10:05:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/10/2025 08:17:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2025 08:15:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/08/2025 02:58:10 PM

